PGXL has installed the faster and more analytically powerful Version 2 DEPArrayTM. The system isolates individual, intact cells, enabling researchers to study rare cells in disease development, progression and therapeutic response.
Image-based cell identification and the ability to electromagnetically capture and manipulate individual cells enables the isolation of specific rare cells, leaving behind the contaminants, cell fragments and false positives that can confound downstream analysis. In addition, the DEPArray’s movement of cells is so gentle that living cells can be recovered directly to culture plates.
PGXL Technologies is the only company offering DEPArray service on a contract basis.
Further information and technical specs on the DEPArray are available here.